Search For "astrazeneca"
DCGI sends show cause notice to Serum Institute for not pausing trial of
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
Read More
Oxford COVID-19 vaccine trials not paused in India, clarifies Serum Instit
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Read More
Weak global cues drag down equity indices, banking stocks suffer
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 9 (ANI): Equity benchmark indices closed in the negative zone on Wednesday following losses in Asian markets after yesterday's rout in Wall Street.
Read More
Equity indices dip amid weak global cues, PSU banks and metals drag
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 9 (ANI): Equity benchmark indices traded lower during early hours on Wednesday following losses in Asian markets after yesterday's rout in Wall Street.
Read More
AstraZeneca says COVID-19 vaccine trial paused due to unexplained illness
Updated : 5 years, 6 months ago IST
London [UK], September 9 (ANI): UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom.
Read More
AstraZeneca's vaccine has reached Phase 3 clinical trials in US: Trump
Updated : 5 years, 6 months ago IST
Washington DC [USA], Sep 1 (ANI): US President Donald Trump on Monday announced AstraZeneca's COVID-19 vaccine has reached Phase 3 clinical trials in the United States and is very close to being finalised for approval.
Read More
UK's AstraZeneca begins human trial of COVID-19 treatment using monoclonal
Updated : 5 years, 7 months ago IST
London [UK], Aug 25 (ANI/Sputnik): UK-based pharmaceutical company AstraZeneca announced on Tuesday that it had begun the human trial of a new treatment for COVID-19 using a combination of two monoclonal antibodies.
Read More
Wockhardt announces Covid-19 vaccine partnership with UK government
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 3 (ANI): Pharmaceutical and biotechnology major Wockhardt said on Monday it has entered into an agreement with the UK Government to fill-finish Covid-19 vaccines.
Read More
UK signs deals to buy 90 million doses of two coronavirus vaccine candidat
Updated : 5 years, 8 months ago IST
London [UK], July 20 (ANI): The UK government has signed agreements to buy 90 million doses of two promising COVID-19 vaccine candidates.
Read More
Brazil announces agreement with UK to produce COVID-19 vaccine
Updated : 5 years, 9 months ago IST
Sao Paulo [Brazil], June 28 (Xinhua/ANI): The Brazilian Ministry of Health on Saturday announced an agreement with the United Kingdom to acquire technology to locally produce a vaccine against COVID-19, that is, currently being developed by the University of Oxford and British pharmaceutical
Read More
Cipla receives final approval for generic version of AstraZeneca Pharmaceu
Updated : 5 years, 12 months ago IST
Mumbai (Maharashtra) [India], Mar 27 (ANI/ PRNewswire): Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla" today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Esomeprazole for Oral Suspension 10mg, 20mg and 40m
Read More
Sun Pharma, AstraZeneca enter into license pact for novel oncology product
Updated : 6 years, 4 months ago IST
Mumbai (Maharashtra) [India], Nov 6 (ANI): Sun Pharmaceutical Industries said on Wednesday it has entered into a licensing agreement with AstraZeneca UK Ltd to introduce certain novel ready-to-use infusion oncology products in China.
Read More